Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 1815

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.11, p 0.775). This receipt's hash covers every field on it, plus the hash of receipt 1814, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 1815
    18 Oct 2026, 07:09 UTC

    CTNNA2

    dopamine neurons, braak

    predictionCTNNA2 in dopamine neurons tracks Braak Lewy-body stage

    registered69be8d1c7a4be1d1

    discovery-0.11 p=0.775 n=9

    replication+0.61 p=0.078 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.11, p 0.775)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    3f2d1f03f2740be2712af75b…
    follows 4c276dcc7cc6…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 1815: CTNNA2 in dopamine neurons, braak

power
full sample +0.18 (p 0.482, n 18), 95% CI -0.32 to +0.59. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.15 (p 0.555, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.15 (p 0.555, n 18). could be the mix.
skeptic
leave-one-out range +0.10 to +0.32, sign flips 0; without severely affected donors +0.18 (p 0.482, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for CTNNA2 in dopamine neurons.

case closed: nothing better to follow up.